Downloading...
Download

Tilraybrands

Tilray Brands Unveils Exciting 420 Product Lineup: Stock up 18%As the cannabis industry continues to evolve, Tilray Brands, Inc. ( NASDAQ:TLRY ) emerges as a frontrunner in the global cannabis lifestyle and consumer packaged goods market. In a recent announcement, Tilray ( NASDAQ:TLRY ) unveiled its latest product lineup and 420 celebratory activations across Canada, offering consumers an array of diverse cannabis products from its leading brands. Tilray Brands ( NASDAQ:TLRY ), known for its commitment to quality and innovation, showcases an impressive selection of flower, beverages, pre-rolls, and vapes, catering to both seasoned cannabis enthusiasts and curious newcomers alike. Flower Selection: Redecan Space Age Cake, Good Supply Melon Dream, and Broken Coast EmergenZ and Cherry Cheesecake are among the standout strains offered, each boasting unique aromas and taste profiles that promise to elevate the cannabis experience. Beverage Innovation: XMG+ Non-Carbonated Banana Brain-Freeze and Berry Rocket, Solei Cold Brews in Peach Cranberry and Wildberry Hibiscus, and Mollo Seltzers in Lemon, Mango, and Pineapple showcase Tilray's commitment to providing consumers with innovative and refreshing beverage options infused with THC and other cannabinoids. Pre-Rolls for Convenience: Good Supply's 'Cherry on Top' Blunts, Redecan Hemp'd Khalifuel Redees, and Canaca Darts in Berries & Cream and Twisted Citrus offer convenient and pre-rolled options for consumers seeking quality and consistency. Vape Excellence: Good Supply Gooey Gold and Cherry Loops vapes deliver high potency and rich flavors, enhancing the vaping experience with every inhale. In celebration of 420, Tilray Brands invites consumers to explore these exciting new products through a series of educational budtender events hosted in partnership with over 1000 Canadian cannabis retailers nationwide. These events offer a unique opportunity for consumers to learn about Tilray Brands' products and the ever-changing landscape of cannabis innovation and culture. With a commitment to quality, diversity, and consumer satisfaction, Tilray Brands ( NASDAQ:TLRY ) continues to push the boundaries of cannabis innovation, setting the standard for excellence in the industry. Whether it's the creamy vanilla notes of Redecan Space Age Cake or the tropical sweetness of XMG+ Non-Carbonated Banana Brain-Freeze, Tilray Brands offers something for every cannabis enthusiast to enjoy. Technical Outlook Tilray Brands Inc. ( NASDAQ:TLRY ) stock is up by 18.26% prior to new product lineup news. In our recent technical Outlook on Tilray Brands ( NASDAQ:TLRY ) stock, we predicted the stock to spark a bullish breakout after forming a symmetrical triangle pattern. which did fill the order. Wednesday, 4th April 2024. NASDAQ:TLRY is trading above the 200-day Moving Averages (MA) with a bullish Relative Strength Index (RSI) of 77.82 indicating an overbought position or continuation of the current trend.
NASDAQ:TLRY
by DEXWireNews
3
Tilray's 8% Surge: High-Risk Gamble or a Path to Redemption?Tilray Brands (NASDAQ: NASDAQ:TLRY ), once a shining star in the cannabis industry, finds itself in turbulent waters as its stock price struggles amidst a series of setbacks last week. Despite aggressive growth through acquisitions, Tilray's stock has plummeted, trailing behind major indices and leaving investors questioning the efficacy of its strategy. The Acquisition Frenzy: Tilray's growth trajectory has been marked by a flurry of acquisitions, positioning itself as a major player in both the cannabis and alcoholic beverages markets. From snapping up eight beer brands from AB InBev to acquiring Truss Beverage from Molson Coors, Tilray seemed determined to diversify its revenue streams and mitigate the inherent risks of the cannabis industry. Revenue Growth vs. Mounting Losses: While acquisitions have propelled Tilray's revenue growth, with annual revenues soaring from $179.3 million in 2019 to over $700 million in the trailing twelve months, the company's bottom line tells a different story. Net losses have ballooned, surging from $36.1 million in 2019 to over $1.4 billion in the same period, raising concerns about the sustainability of its expansion strategy. Cannabis vs. Beverages: A Shifting Landscape: Despite its roots in cannabis, Tilray's focus seems to be shifting towards alcoholic beverages, evident in its recent revenue breakdown. While the cannabis segment still contributes significantly to its revenue, the beverages segment is gaining ground, a trend likely to continue as integration efforts persist. Challenges on Multiple Fronts: Tilray ( NASDAQ:TLRY ) faces an array of challenges, both domestically and internationally. In Canada, its home market, saturation is squeezing margins, while regulatory hurdles in the United States pose obstacles to expansion. Even in Germany, touted as a potential growth market, barriers loom large, underscoring the uphill battle Tilray faces in realizing its ambitious revenue targets. Stock Price Forecast: Tilray's ( NASDAQ:TLRY ) stock price paints a bleak picture, with a strong downward trend persisting throughout the year. Despite its downward trend, Tilray ( NASDAQ:TLRY ) stock was up 8% in early market trading this could be a sign of a bullish breakout after the stock's poor performance last year. Technical indicators suggest that further downside could be in store, with key support levels looming as potential targets.
NASDAQ:TLRYLong
by DEXWireNews
TLRY Tilray Brands Options Ahead of EarningsIf you haven`t bought TLRY here: Then analyzing the options chain and the chart patterns of TLRY Tilray Brands prior to the earnings report this week, I would consider purchasing the 2.50usd strike price Calls with an expiration date of 2024-3-15, for a premium of approximately $0.55. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. Looking forward to read your opinion about it.
NASDAQ:TLRYLong
by TopgOptions
2
No rest for Tilray?Tilray Short Term - We look to Sell at 5.33 (stop at 5.87) Our outlook is bullish. A mild correction has been posted from yesterdays high, this is seen as a retest of the breakout level. The hourly chart technicals suggests further upside before the downtrend returns. The bias is still for lower levels and we look for any gains to be limited. Our profit targets will be 3.92 and 3.18 Resistance: 5.50 / 8.50 / 15.00 Support: 4.00 / 3.00 / 2.00 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
NASDAQ:TLRYShort
by Saxo
Tilray Brands (USA: $TLRY) Investors About To Get Lucky 🍀Tilray Brands Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. It operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. The company provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. It offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. The company operates Tilray Medical, a medical platform that provides GMP-certified flowers, oils, vapes, edibles, and topicals. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Tilray, Inc. Tilray Brands Inc. was incorporated in 2018 and is headquartered in New York, New York.
NASDAQ:TLRYLong
by DEXWireNews
4